XML 69 R57.htm IDEA: XBRL DOCUMENT v3.23.2
Business Segment Information - Summary of EBIDTA by Reporting Segment (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Segment Reporting Information [Line Items]        
Consolidated adjusted EBITDA $ 9,919 $ 11,423 $ 13,123 $ 18,532
Interest expense, net 1,266 407 2,555 782
Depreciation and amortization 13,327 6,512 25,997 14,028
Share-based compensation expense 13,246 4,460 26,266 8,792
Foreign exchange impact (269) 2,991 (852) 4,233
SeaSpine merger-related costs 8,206   28,946  
Strategic investments 309 1,824 970 2,794
Acquisition-related fair value adjustments 8,149 (10,714) 19,785 (16,214)
Legal judgments/settlements 1,291 148 1,760 341
Medical device regulation 2,050 2,248 5,679 4,198
Business interruption - COVID-19   316   659
All other 262 189 262 266
Income (loss) before income taxes (37,918) 3,042 (98,245) (1,347)
Operating Segments [Member] | Global Spine [Member]        
Segment Reporting Information [Line Items]        
Consolidated adjusted EBITDA 21,258 14,610 36,239 28,643
Operating Segments [Member] | Global Orthopedics [Member]        
Segment Reporting Information [Line Items]        
Consolidated adjusted EBITDA (135) 780 (91) (24)
Corporate, Non-Segment [Member]        
Segment Reporting Information [Line Items]        
Consolidated adjusted EBITDA $ (11,204) $ (3,967) $ (23,025) $ (10,087)